- Home
- AARD vs HDRN Comparison
AARD vs HDRN Comparison
Compare AARD & HDRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.35
Company Overview
Basic Information| Metric | AARD | HDRN |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | 40 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.8M | 193.8M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | AARD | HDRN |
|---|---|---|
| Price | $6.35 | $1.95 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.29 | N/A |
| AVG Volume (30 Days) | ★ 439.3K | 70.6K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $1.71 |
| 52 Week High | $17.94 | $2.63 |
Technical Indicators
Market Signals| Indicator | AARD | HDRN |
|---|---|---|
| Relative Strength Index (RSI) | 58.05 | 34.90 |
| Support Level | $4.76 | $1.78 |
| Resistance Level | $11.37 | $2.06 |
| Average True Range (ATR) | 0.93 | 0.18 |
| MACD | 0.12 | 0.00 |
| Stochastic Oscillator | 52.06 | 38.10 |
Price Performance
Historical Comparison AARD
HDRN
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.